US 10093629
Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors
granted A61KA61K31/4375A61K31/472
Quick answer
US patent 10093629 (Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/4375, A61K31/472, A61K31/4741, A61P